Background
The purpose of this project is to test an entirely new strategy for reactivating cell death in pediatric leukemias that are otherwise resistant to chemotherapy treatment. The Walensky laboratory has recently discovered a new class of molecules that directly bind to a unique interaction site on BAX, which is an essential "killer" protein of the cell, enhancing its conformational activation in response to cell stress.
